Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)

Note 7 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Mar. 31, 2019

Consolidated Stockholders' Equity Statement [Table Text Block]

	Common Stock						Additional Paid-in		Retained			Accumulated Other Comprehensive
	Shares			Amount			Capital		Earnings			Income(Loss)			Total
Balances at June 30, 2018		37,608		$	376		$	246,568	$	876,931		$	(44,814	)	$	1,079,061
Cumulative effect adjustments due to adoption of new accounting standards										24,780			(24,682	)		98
Net earnings										17,403						17,403
Other comprehensive loss													(1,136	)		(1,136	)
Share repurchases																-
Surrender and retirement of stock to exercise options																-
Common stock issued for exercise of options		166			2			15,609								15,611
Common stock issued for restricted stock awards		24			0					(1,909	)					(1,909	)
Cash dividends										(12,066	)					(12,066	)
Stock-based compensation expense								11,327								11,327
Common stock issued to employee stock purchase plan		5			0			842								842
Employee stock purchase plan expense								238								238
Balances at September 30, 2018		37,803		$	378		$	274,584	$	905,139		$	(70,632	)	$	1,109,469
Net earnings										17,556						17,556
Other comprehensive loss													(12,379	)		(12,379	)
Share repurchases		(95	)		(1	)				(15,404	)					(15,404	)
Surrender and retirement of stock to exercise options																-
Common stock issued for exercise of options		24			0			2,408								2,408
Common stock issued for restricted stock awards		3			0					0						-
Cash dividends										(12,086	)					(12,086	)
Stock-based compensation expense								6,784								6,784
Common stock issued to employee stock purchase plan		0			0											-
Employee stock purchase plan expense								77								77
Balances at December 31, 2018		37,735		$	377		$	283,854	$	895,205		$	(83,011	)	$	1,096,425
Net earnings										44,654						44,654
Other comprehensive income													3,378			3,378
Share repurchases																-
Surrender and retirement of stock to Exercise options																-
Common stock issued for exercise of Options		73			1			7,336								7,337
Common stock issued for restricted stock Awards		1			0											-
Cash dividends										(12,086	)					(12,086	)
Stock-based compensation expense								5,640								5,640
Common stock issued to employee stock Purchase plan		4			0			834								834
Employee stock purchase plan expense								84								84
Balances at March 31, 2019		37,813		$	378		$	297,748	$	927,773		$	(79,633	)	$	1,146,266

	Common Stock				Additional Paid-in		Retained			Accumulated Other Comprehensive
	Shares		Amount		Capital		Earnings			Income(Loss)			Total
Balances at June 30, 2017		37,356	$	374	$	199,161	$	799,027		$	(48,935	)	$	949,627
Net earnings								15,863						15,863
Other comprehensive loss											(824	)		(824	)
Surrender and retirement of stock to exercise options														0
Common stock issued for exercise of options		33		0		3,051								3,051
Common stock issued for restricted stock awards		13		0				(227	)					(227	)
Cash dividends								(11,958	)					(11,958	)
Stock-based compensation expense						3,718								3,718
Common stock issued to employee stock purchase plan		7		0		755								755
Employee stock purchase plan expense						77								77
Balances at September 30, 2017		37,409	$	374	$	206,762	$	802,705		$	(49,759	)	$	960,082
Net earnings								48,847						48,847
Other comprehensive loss											(7,058	)		(7,058	)
Surrender and retirement of stock to exercise options														-
Common stock issued for exercise of options		38		1		2,892								2,893
Common stock issued for restricted stock awards		22		0				0						-
Cash dividends								(11,988	)					(11,988	)
Stock-based compensation expense						4,985								4,985
Common stock issued to employee stock purchase plan		-				-								-
Employee stock purchase plan expense						59								59
Balances at December 31, 2017		37,470	$	375	$	214,697	$	839,564		$	(56,817	)	$	997,819
Net earnings								19,738						19,738
Other Comprehensive Loss											40,956			40,956
Surrender and retirement of stock to Exercise options														-
Common stock issued for exercise of options		68				6,273								6,273
Common Stock issued for restricted stock awards														-
Cash dividends								(11,992	)					(11,992	)
Stock-based compensation expenses						4,669								4,669
Common stock issued to employee stock purchase plan		7				752								752
Employee stock purchase plan expense						78								78
Balances at March 31, 2018		37,545	$	375	$	226,469	$	847,310		$	(15,862	)	$	1,058,292

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Unrealized
	Gains						Unrealized
	(Losses) on			Foreign			Gains
	Available-			Currency			(Losses) on
	for-Sale			Translation			Derivatives
	Investments			Adjustments			Instruments			Total
Beginning balance as of June 30, 2018	$	24,682		$	(69,496	)	$	-		$	(44,814	)
Cumulative effect adjustment for adoption for ASU 2018-02 (1)		2,371			-			-			2,371
Cumulative effect adjustment for adoption for ASU 2016-01 (1)		(27,053	)		-			-			(27,053	)
Other comprehensive income (loss), net of tax benefit of $1,792 on derivative instruments (2)		-			(4,368	)		(5,769	)		(10,137	)
Ending balance as of March 31, 2019	$	-		$	(73,864	)	$	(5,769	)	$	(79,633	)

	Unrealized
	Gains					Unrealized
	(Losses) on		Foreign			Gains
	Available-		Currency			(Losses) on
	for-Sale		Translation			Derivative
	Investments		Adjustments			Instruments		Total
Beginning balance as of June 30, 2017	$	18,989	$	(67,924	)	$	-	$	(48,935	)
Other comprehensive income (loss)		22,286		10,787			-		33,073
Ending balance as of March 31, 2018	$	41,275		(57,137	)	$	-	$	(15,862	)